J&J COVID-19 Vaccines Authorized for Worldwide Deployment

In COVID-19, Latest News by Precision Vaccinations

The U.S. Food and Drug Administration (FDA) confirmed it is taking action to supply the Janssen (Johnson & Johnson) COVID-19 Vaccine to be made available in the USA and globally.
On June 11, 2021, the FDA announced that it is authorizing for use under the emergency use authorization (EUA) for the Janssen COVID-19 vaccine, two batches of vaccine drug substance previously manufactured at the Emergent BioSolutions facility in Baltimore, MD.

Read More